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Protein identification and profiling is critical for the advancement of cell and  molecular  biol-
ogy as well as medical diagnostics. Although mass spectrometry and protein microarrays are 
commonly used for protein identification, both methods require extensive experimental steps and 
long data analysis times. Here we present a microfluidic top down proteomics platform giving 
multidimensional read outs of the essential amino acids of proteins. We obtain hydro- dynamic 
radius and fluorescence signals relating to the content of tryptophans, tyrosines and lysines of 
proteins using a combination of diffusional sizing of proteins, label-free  detection and on-chip 
labelling of proteins with a latent fluorophore in the solution phase. We thereby achieve 
identification of proteins on a single microfluidic chip by separating and mapping proteins in 
multidimensional space based on their characteristic physical parameters. Our results have 
significant implications in the development of easy and rapid platforms to use for native protein 
identification in clinical and laboratory settings.  
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1   Introduction  
Top down proteomic studies are of vital importance in adding to our fundamental knowledge of the 
human proteome as well as in  the advancement of modern medicine.  Indeed, proteomic studies on  
cancer cells and cerebrospinal fluid samples in Alzheimer’s disease patients have provided precious 
insights into the mechanism of  disease  progression.1–6  Currently, mass spectrometry is one of the  
most popular  techniques  available  for  top-down  proteomics  due to  its high sensitivity,  resolution,   
mass accuracy  and  dynamic range.7, 8   Scientists  also tried to combine tandem mass spectrometry  
with microfluidic method to identify proteins.9 However, proteins are identified in the gas phase, 
typically  by comparing protein mass  spectra to  predetermined sequence databases.10–14  Another 
widely used method for identification is protein microarrays, which target proteins using analyte 
specific reagents such as antibodies, allowing quantitative information on the species present to be 
obtained.15,16 It has been speculated that advances in protein identification studies could provide 
valuable information for the development of novel disease biomarkers, treatments in personalised 
medicine and targeted therapeutics, leading to the rise of a new generation of pharmaceuticals.17–23 
However, the currently available top down proteomic methods require extensive sample preparation 
steps, specialized mass spectrometry equipment and long experimental analysis times, and as of yet 
cannot be feasibly implemented in clinical settings.  
Here, we propose a proof-of-principle technique which combines multidimensional data from 
microfluidic measurements on the physical parameters of proteins to achieve the resolution and 
sensitivity required for protein identification on a single microfluidic chip. We measure the protein 
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hydrodynamic radius, detect label-free fluorescence intensity of tryptophan and tyrosine, as well as 
measure lysine residues that are labelled with a latent fluorophore. Each protein  tested here has a  
unique combination of these four parameters, allowing us to separate and identify the proteins by 
mapping the ratio of the obtained  parameters in  multidimensional space.  We thereby can identify 
those proteins tested here and demonstrate the potential that our novel microfluidic method has in the 
further development of top down proteomic assays for use in clinical diagnostic settings and in 
biophysical research laboratories for quick and easy protein identification.  
2   Results and Discussion  
Microfluidic top-down proteomics measurements   The top-down proteomics device designed in  
this study consists of a diffusional sizing module and latent labelling module, allowing the protein 
hydrodynamic  radius and characteristic  fluorescence intensities from  tryptophans, tyrosines and  
lysine  to be determined  in  the solution phase  in a  single  measurement.23,24  The hydrodynamic  
radius of  proteins and intrinsic  fluorescence intensity  for  tryptophan and  tyrosine are detected by  
our home-built microscope (Fig. 2) incorporate with deep UV-LED excitation at 280 nm. However, 
related fluorescence of lysine is detected by OPA-LED excitation at 365 nm light, which is because 
proteins were labelled with ortho-phthalaldehyde (OPA) fluorescence labelling dye to interact with 
primary amine group24. In order to calibrate the variations of fluorescence intensity of PDMS mi- 
crofluidic devices under different daily experiments, we performed a calibration measurement where 
we separately imaged two different solutions (tryptophan and 4-methylumbelliferone (4MU)) of standard 
molecules of known concentrations with UV and OPA excitation wavelengths respectively  (calibration 
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channel,  Fig. 2).  After calibration,  we used our  intrinsic  fluorescence set-up fitted with  a  tryptophan  
emission  filter  at  350 nm  to  size the  native  proteins  by  imaging  the extent  of  their  lateral  
diffusion  into  auxiliary buffer  streams  under  steady laminar flow (sizing region, Fig. 2).23   At the 
end of the diffusion channel we then imaged the characteristic tryptophan fluorescence (W detection 
region, Fig. 2).   The  emission  filter  was  then changed  to  305 nm  in order  to measure the related 
tyrosine fluorescence intensity for native proteins  (Y detection region,   Fig. 2).   The tyrosine intensity 
was normalised by local background correction algorithm as previously described. Downstream of the 
sizing  and  the W detection regions, we  used an on-chip  latent labelling  strategy  described  previously 
to  conjugate  the protein’s  lysine residues  to  OPA  dye molecules.24 The OPA labelling dye mixed 
with the protein via lateral diffusion. Thus, the characteristic fluorescence intensity from the lysine 
residues was imaged by switching the UV-LED light source at 280 nm wavelength to an OPA-LED 
light source at 365 nm wavelength.  
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Figure 1  The microfluidic top down identification device.  The protein hydrodynamic   radius 
is measured in the sizing region (pink) and the related intrinsic tryptophan (W) and tyrosine 
(Y) fluorescence intensities are imaged under UV excitation280 nm in the yellow and green 
regions, respectively. The light source is then switched to 365 nm excitation and the OPA 
fluorescence intensity coming from the protein’s lysine residues (K) conjugated to OPA dye is 
imaged in the blue region.  Before each experiment, standard dye molecules of known 
concentrations (tryptophan and 4MU) are imaged separately in the calibration channel to 
account for fluctuations of background fluorescence of PDMS. Because of the protein 
diffusion, both the W fluorescence intensity detection region and K detection region are not 
fully fluorescent at the detection region. 
 
 6 
                            
Figure 2 Schematic representation of the home-built inverted fluorescence microscope 
used for visualisation of proteins in this work. The user is able to easily switch between 
two light sources of wavelength 280 nm and 365 nm using a flip mirror, and to change 
emission filters according to the amino acid residue under investigation. 
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Protein identification in multidimensional space   In order to perform the multidimensional data 
analysis for protein identification, variations in sample concentration should also be considered. The 
imaged fluorescence intensities of the tryptophan, tyrosine and lysine residues were normalised for  
each repeat in each protein by protein absorbance measurements. Moreover, the three normalised 
fluorescence traces were converted into two fluorescence intensity ratios -  Wn/Yn and Yn/Kn   - to 
eliminate  the  concentration dependence.  The protein concentration independent hydrodynamic radius 
was used to map the position of each of the seven proteins in multidimensional (Fig. 2).  
For  each  of  the  seven areas  along each  of  the  axes  the centre of the area  was plotted as  
the average of the three repeat measurements (μ) taken for the specific protein and the standard 
deviations (σ) along each of the three axes were calculated as the average of the seven individual 
standard deviations along that particular axis. Furthermore, the fourth test point obtained for each 
protein was randomly selected and the probability was calculated, then multiplied together to obtain  
the overall probability that the  fourth test point would be identified as each protein in the database.  
Using this method,  the heat map of the probabilities was plotted as shown in  Fig. 3.  However, it is 
hard to distinguish BSA and ovalbumin based on our database.  
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Figure 3 The multidimensional data analysis for protein identification with top-down 
proteomics microfluidic device.  
	
3    Conclusions  
In summary,  we are able to identify  proteins of  varying molecular weights and sequence in their 
native states by measuring their hydrodynamic radii and fluorescence intensities related to their 
tyrosine, tryptophan and lysine contents using a microfluidic  top-down approach described in this 
work. Using the method described, we were able to obtain multidimensional information for a given 
protein in a single experiment. Because of its simplicity and low sample consumption, this method is 
also usable for detecting protein-protein interactions, protein stability and mobility, as well as available 
for clinical diagnostic assays.   
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Methods  
Preparation of samples and labelling dye   The proteins and their corresponding  concentrations 
tested were: BSA (15μM and  30μM, Sigma Aldrich), β-lactoglobulin  (β-lac) (353μM,  Sigma 
Aldrich), glucose oxidase (30μM and 114μM), α-lactalbumin (α-lac) (231μM, Sigma Aldrich), 
ovalbumin (232μM), alcohol dehydrogenase (92μM and 140μM, Alfa Aesar), and human transferrin 
(100μM). All the proteins were prepared in the 25 mM phosphate buffer (pH 8).  
Solutions for calibration at 280 nm and 365 nm were 10μM L-Tryptophan and 1μM 4MU, 
respectively, both in 400 mM potassium borate buffer (pH 9.7).  These solutions were imaged 
separately on every chip in the detection regions of the calibration channels adjacent to the top-down 
identification microfluidic device.  
The standard labelling solution was prepared with 12 mM OPA, 18 mM β-mercapto ethanol 
(BME) and 4% wt/vol sodium dodecyl sulfate (SDS) in 200 mM carbonate buffer, pH 10.5.  
UV-LED microscope   The  schematic of optical layout is  shown in Fig. 2.  Light  from a 280 nm 
LED (Thorlabs M280L3) and 365 nm LED (Thorlabs M365L2) are individually selected depending 
upon  the  experiment  by  a  flip  mirror.  The  light is  passed through an  aspherical lens of focal 
length 20 mm to get a nearly collimated  output beam.  The beam is then incident on a filter cube,  
which consists of an excitation filter, dichroic mirror and an emission filter. Light reflected by the 
dichroic mirror is focused onto the sample flowing in a microfluidic chip by an infinity corrected UV 
objective lens (Thorlabs LMU-10X-UVB) of numerical aperture NA=0.25. The emitted fluorescent 
light from the sample  is collected through the same objective,  an emission filter,  and thereafter  
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focused onto a EMCCD camera (Rolera EM-C2) by a tube lens of focal length 200 mm. All the optics 
used in the set-up are made out of fused silica for high transmission in the UV region. 
Microfluidic device fabrication and experiments Microfluidic devices were cast using poly- 
dimethylsiloxane  (PDMS ) (Sylgard 184 kit, Dow Corning) from a silicon wafer master imprinted  
with the device channels 50μm high based on standard soft-lithography techniques25. Carbon black 
nano-powder (Sigma-Aldrich) was added to the PMDS before curing to create black devices, thus 
minimising  unwanted  autofluorescence  from PDMS  under UV  illumination during the measure- 
ments. Devices were bonded to a quartz slide (Alfa Aesar,  76.2x25.4x1.0mm) using a  plasma 
treatment (Electronic Diener Femto plasma bonder).  The channels were then filled from the outlet  
with phosphate buffer using a glass syringe  (Hamilton, 500μL),  needle (Neolus Terumo, 25 gauge,  
0.5 x 16mm), and polyethene tubing (Scientific Laboratory Supplies, inner diameter 0.38mm, outer 
diameter 1.09mm).  
The sample, buffer and labelling solution were loaded in their respective device inlets using  
gel loading pipette tips. The calibration channel was filled in the same way and the standard UV 
calibration solution was loaded in a gel pipette tip. Fluid flow through the channels was controlled 
using neMESYS syringe pumps (Cetoni GmbH) at a flow rate of 200 μLh−1 in the top-down 
identification channels and 80 μLh−1 in the calibration channel.  
Once the flows stabilised, hydrodynamic radii of proteins were measured and fluorescence 
intensities of tryptophan and tyrosine were detected using our UV-LED set-up fitted with the 
appropriate emission filter  (Tryptophan: 350 nm; Tyrosine: 305 nm),  and excitation wavelength of 
 11 
280 nm. In order to get the fluorescence intensity related to the protein’s lysine content, OPA dye 
solution  was mixed  with the  protein on-chip  via lateral diffusion from both sides,  with a  mixing 
time of at least 3 s  at a flow rate of 200 μL h−1   to ensure fully labelling.  The OPA detection region 
in the top-down channels and the calibration channels as well as the background were then imaged 
using our set-up fitted with a 365 nm LED and corresponding dichroic filter set. The protein 
fluorescence intensities were calculated from the acquired images using ImageJ (see details in 
Supporting information).  
Data Analysis   The  hydrodynamic radii of the  proteins were calculated based on 12 images along 
the diffusion channel.  The 12  images were processed to produce a set  of  2D  diffusion profiles,  
which were then fitted to a set of simulated basis functions (Fig. S). These basis functions contain 
information  both on the  spatial  diffusion  (along the channel width) and temporal diffusion  (along 
the channel length), which allows the sample diffusion coefficients to be determined. A maximal 
entropy basin  hopping  algorithm with a  Broyden-Fletcher-Goldfarb- Shannon  minimization was 
used to fit a linear combination of the simulated basis functions to the experimental diffusion profile, 
yielding the average radius of the analyte23. 
Based on our approach described, multi-information  of proteins can be determined.  To 
perform the multidimensional data analysis, we first normalised the fluorescence intensities for each 
repeat in each protein by protein absorbance using the following equations:  
𝑊! = 𝑊𝑊"#$	 	 ∙ 𝐴&'(		
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where Wn, Kn and Yn are  the  normalised  tryptophan,  lysine or tyrosine intensities,  W,  K 
and Y are the tryptophan, lysine and tyrosine intensities obtained in the microfluidic measurement, Wcal 
and Kcal are the intensities of the standard UV and OPA calibration solutions for background correction, 
and A280  is the  absorbance of the  protein.  
We then calculated the average  (μ)  and standard deviation  (σ)  of  each  parameter  (Wn, Kn, 
Yn and Rh) across three repeats for each protein to define the 3D space. In order to eliminate the 
concentration dependence the three fluorescence traces were converted into two fluorescence intensity 
ratios - Kn/Wn and Kn/Yn.  
The fourth data point was randomly selected and used as a test point for protein identification. In 
order to identify the test proteins within the multidimensional space were modelled as standard normal 
distributions N (μ, σ)  with μ and σ determined as previously described.  Such distributions were 
obtained for all the seven proteins along  all the axes.  The z-scores were then calculated under the  
assumption  of  each  of  the  test points  being each  of  the seven proteins . All the z-scores were 
converted into the probabilities given the specific normal distribution and the three probabilities were 
(1) 
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multiplied and converted to logarithm.  Then, the products of the probabilities were plotted in the Fig. 
2, y-axis and as such the probabilities are normalised along each row.  
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Figure 1  The microfluidic top down identification device.  The protein hydrodynamic   
radius is measured in the sizing region (pink) and the related intrinsic tryptophan (W) and 
tyrosine (Y) fluorescence intensities are imaged under UV excitation280 nm in the yellow 
and green regions, respectively. The light source is then switched to 365 nm excitation and 
the OPA fluorescence intensity coming from the protein’s lysine residues (K) conjugated to 
OPA dye is imaged in the blue region.  Before each experiment, standard dye  molecules 
of known concentrations (tryptophan and 4MU) are imaged separately in the calibration 
channel to account for fluctuations of background fluorescence of PDMS. Because of the 
protein diffusion, both the W fluorescence intensity detection region and K detection region 
are not fully fluorescent at the detection region. 
 
 
 
 
 
 
 
 
Figure 2 Schematic representation of the home-built inverted fluorescence microscope 
used for visualisation of proteins in this work. The user is able to easily switch between 
two light sources of wavelength 280 nm and 365 nm using a flip mirror, and to change 
emission filters according to the amino acid residue under investigation. 
 
 
 
 
 
 
 
 
Figure 3 The multidimensional data analysis for protein identification with top-down 
proteomics microfluidic device.  
